May 10, 2018 by Chain Drug Review
Actifio, Apotex, Ash Ashutosh, data protection, database recovery, Ernesto Nigro
Technology
WALTHAM, Mass. and TORONTO — Actifio has announced details of how its platform has sped database recovery times by 96% and cut storage costs by 60% at Apotex, the largest Canadian-owned generic pharmaceutical company. The seventh-largest generic pharmaceutical company globally with estimated sales of approximately $2 billion, Apotex produces high-quality, affordable generic and innovative pharmaceutical
December 17, 2017 by Chain Drug Review
Apotex, Barry Sherman
Leading Headlines, Pharmacy, Supplier News
TORONTO — Police are investigating the deaths of Barry Sherman, the founder of Apotex Inc., and his wife Honey, whose bodies were found at their North York, Ontario, home on Friday. As of Sunday, autopsies on Sherman and his wife were pending, published reports said. Authorities said the results will help determine the next steps
February 23, 2017 by Chain Drug Review
Apotex, Cardinal Health, Craig Cowman, Genentech, Greg Drew, HDA, HDA Executive Committee, HDA Research Foundation, Healthcare Distribution Alliance, James Reilly, Jeffrey Hampton, John Gray, Morris & Dickson, Paul Dickson, Value Drug
Supplier News
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) has made new appointments to its executive committee and HDA Research Foundation board of directors. HDA said Thursday that Paul Dickson, president of Morris & Dickson Co., has been elected as a member of the HDA Executive Committee. He currently serves as a member of the HDA
February 14, 2017 by Chain Drug Review
AAM, Apotex, Association for Accessible Medicines, biosimilars, Chip Davis, generic drugs, Generic Pharmaceutical Association, GPhA, GPhA Annual Meeting, Heather Bresch, Jeff Watson, Lupin Pharmaceuticals, mylan, Paul McGarty, Peter Goldschmidt, Sandoz
Featured Articles, Leading Headlines, Pharmacy, Supplier News
WASHINGTON — The Generic Pharmaceutical Association (GPhA), which represents manufacturers of generic drugs and biosimilars, has changed its name to the Association for Accessible Medicines (AAM). The association said Tuesday that the new name better reflects its mission: to make medications more accessible to the people who need them. As GPhA, the trade group had steadfastly
July 12, 2016 by Chain Drug Review
Apotex, Arthur Bedrosian, Lannett, paroxetine extended-release tablets, Paxil CR
Pharmacy, Supplier News
PHILADELPHIA — Lannett Co. has been cleared by the Food and Drug Administration to market paroxetine extended-release tablets, an antidepressant, in strengths of 12.5 mg, 25 mg and 37.5 mg. The company said its product, a generic version of Paxil CR extended-release tablets (12.5 mg, 25 mg and 37.5 mg) from Apotex Technologies, has begun
February 23, 2016 by Chain Drug Review
Apotex, Chip Davis, generic drugs, Generic Pharmaceutical Association, GPhA, GPhA’s 2016 board of directors, Heather Bresch, Jeff Watson, mylan, Par Pharmaceuticals, Tony Pera
Pharmacy, Supplier News
ORLANDO, Fla. — The Generic Pharmaceutical Association (GPhA) has elected Heather Bresch, chief executive officer of Mylan, to chair its board of directors this year. GPhA, which announced the move at its 2016 Annual Meeting here, also named other officers to its 2016 board and executive committee: Jeff Watson, president of global generics at Apotex,
March 23, 2015 by Chain Drug Review and Chain Drug Review
Apotex, Canadian Generic Pharmaceutical Association, Canadian prescription drug market, generic drugs, Jeff Watson, Larry MacGirr, Pharmascience
Pharmacy, Supplier News
TORONTO — Jeff Watson, president of global generics at Apotex, has been elected as chairman of the Canadian Generic Pharmaceutical Association (CGPA). CGPA also said Monday that Larry MacGirr, chief operating officer of Pharmascience, has been elected as the association’s vice chairman. “It is an honor to serve as chair of CGPA, particularly during this period